rs761330483
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_015909.4(NBAS):c.1987C>T(p.Gln663*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,612,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015909.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NBAS | NM_015909.4 | c.1987C>T | p.Gln663* | stop_gained | 18/52 | ENST00000281513.10 | NP_056993.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NBAS | ENST00000281513.10 | c.1987C>T | p.Gln663* | stop_gained | 18/52 | 1 | NM_015909.4 | ENSP00000281513.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152136Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250344Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135318
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1460452Hom.: 0 Cov.: 30 AF XY: 0.0000234 AC XY: 17AN XY: 726542
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152136Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74296
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | This sequence change creates a premature translational stop signal (p.Gln663*) in the NBAS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NBAS are known to be pathogenic (PMID: 26073778, 26541327, 27789416, 28031453). This variant is present in population databases (rs761330483, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with NBAS-related conditions. ClinVar contains an entry for this variant (Variation ID: 517623). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 10, 2019 | - - |
Infantile liver failure Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 29, 2017 | The p.Gln663X variant in NBAS has not been previously reported in individuals wi th infantile liver failure syndrome. This variant has been identified in 0.027% (9/33434) of Latino chromosomes by the Genome Aggregation Database (gnomAD, http ://gnomad.broadinstitute.org; dbSNP rs761330483). Although this variant has been seen in the general population, its frequency is low enough to be consistent wi th a recessive carrier frequency. This nonsense variant leads to a premature ter mination codon at position 663, which is predicted to lead to a truncated or abs ent protein. Biallelic loss of function of the NBAS gene is assocaited with infa ntile liver failure syndrome. In summary, although additional studies are requir ed to fully establish its clinical significance, the p.Gln663X variant is likely pathogenic for infantile liver failure syndrome in an autosomal recessive manne r based on the predicted impact on the protein. ACMG/AMP Criteria applied: PVS1; PM2 (Richards 2015). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at